No title
Background: Cardiovascular homografts are used for right ventricular outflow tract reconstruction. The procedure has excellent survival rates, but many homografts degenerate and require reintervention. Studies analyzing risk factors for reintervention most often focus on recipient and homograft characteristics, with identification of risk factors such as young recipient age and the use of aortic h
